Development of Class IIa Bacteriocins as Therapeutic Agents

by Christopher T. Lohans, John C. Vederas
Published 2012-01-01

Response of methicillin-resistant Staphylococcus aureus to amicoumacin A.

by Amrita Lama, Jan Pané-Farré, Tai Chon, Anna M Wiersma, Clarissa S Sit, John C Vederas, Michael Hecker, Michiko M Nakano
Published 2012-01-01

Insights into the draft genome sequence of bioactives-producing Bacillus thuringiensis DNG9 isolated from Algerian soil-oil slough

by Mohamed Seghir Daas, Albert Remus R. Rosana, Jeella Z. Acedo, Malika Douzane, Farida Nateche, Salima Kebbouche-Gana, John C. Vederas
Published 2018-10-01

Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication

by Wayne Vuong, Muhammad Bashir Khan, Conrad Fischer, Elena Arutyunova, Tess Lamer, Justin Shields, Holly A. Saffran, Ryan T. McKay, Marco J. van Belkum, Michael A. Joyce, Howard S. Young, D. Lorne Tyrrell, John C. Vederas, M. Joanne Lemieux
Published 2020-10-01

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication

by Wayne Vuong, Muhammad Bashir Khan, Conrad Fischer, Elena Arutyunova, Tess Lamer, Justin Shields, Holly A. Saffran, Ryan T. McKay, Marco J. van Belkum, Michael A. Joyce, Howard S. Young, D. Lorne Tyrrell, John C. Vederas, M. Joanne Lemieux
Published 2020-08-01

Synthesis and investigation of viral cysteine protease inhibitors and biosynthetic studies on subtilosin A

by Miyyapuram, Venugopal
Published 2009